Innovations in MDS and AML Therapeutics with Azacitidine

Created using ChatSlide

Explore the transformative impact of Azacitidine in clinical applications, from its FDA approval for survival benefits to its role in DNA hypomethylation, dosage considerations, and key studies such as CALGB 9221 and AZA-001. Delve into its specific uses for pre- and post-transplantation, elderly patients, and low-risk MDS. Examine safety profiles, common adverse events, and innovative therapy combinations like Venetoclax. Investigate future avenues with Iadademstat and HDAC inhibitors. This...